Sandra Rupp

Sandra Rupp is a Regulatory Affairs Manager dedicated to advancing therapies for individuals with rare and serious diseases, focusing on the EU, UK, Swiss, and MEA regions. They have held various roles at CSL, including Regulatory Affairs Manager for the EU and Regulatory Affairs Scientist for the EU and Switzerland, where they developed and implemented regulatory strategies, managed high-quality submissions, and collaborated with regulatory agencies. Additionally, Rupp has managed regulatory activities across the Middle East and Africa, ensuring compliance and strategic alignment for a diverse product portfolio. They possess a PhD, underscoring their expertise in the regulatory field.